← All trials
NCT06989320
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 27, 2025
- Primary completion
- Dec 31, 2030
- Completion date
- Dec 31, 2031
- First posted
- May 25, 2025
- Last posted
- May 31, 2025
- Enrollment
- 80
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of Alabama, BirminghamLead sponsor
- University of Alabama, BirminghamSponsor investigator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator
- University of Alabama, BirminghamOfficial
- The University of Texas, DallasCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.